Semaglutide has a reported half-life of about 7 days1, so a single dose takes roughly five weeks to substantially clear — and because it is dosed weekly, accumulated levels take even longer to disappear after the final dose.

In plain terms: it leaves slowly, and regular dosing means there is extra on board to leave.

0w2w4w6w8wplateau
Fig. Weekly dosing accumulates: each semaglutide dose lands before the previous has cleared, so levels build toward a plateau (steady-state) over roughly five half-lives. Single-dose decay (grey) versus repeated weekly dosing (gradient). An illustrative model from the published half-life, not a measurement.

The single-dose math

Applying the ~7-day half-life1 to the five-half-lives rule:

Time since doseRemaining
7 days50%
14 days25%
21 days12.5%
28 days6.25%
~35 days~3%

So one dose is largely gone by about five weeks3.

What the pharmacology studies found

Study (cited)ModelKey resultYear
Lau et al.2Molecular design / discoveryEngineered a fatty-acid + albumin-binding modification to make GLP-1 last about a week2015
Overgaard et al.1Human population PK modelConfirmed a half-life of about 1 week, supporting once-weekly dosing2019

In plain terms: the long half-life is not an accident — it was designed in (Lau 2015) and later confirmed in people (Overgaard 2019).

The accumulation caveat

The five-week figure is for a *single* dose. Weekly dosing accumulates toward steady-state, so at the point someone stops there is more on board than one dose — and it clears from that higher starting amount. "Out of your system" after the last dose therefore takes longer than five weeks in practice.

Why the long half-life exists

Semaglutide is engineered for a long half-life through albumin binding2, which is precisely what allows weekly dosing. The same property means a missed dose is cushioned by the slow decay.

These are population estimates. Individual clearance varies. This describes pharmacokinetics, not a personal timeline, and is not medical advice.